{"id":22328,"date":"2021-08-19T08:30:15","date_gmt":"2021-08-19T08:30:15","guid":{"rendered":"https:\/\/evaggelatos.com\/?p=22328"},"modified":"2021-08-19T09:09:32","modified_gmt":"2021-08-19T09:09:32","slug":"22328","status":"publish","type":"post","link":"https:\/\/evaggelatos.com\/?p=22328","title":{"rendered":"\u0395\u03af\u03c4\u03b5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03c4\u03b5\u03af\u03c2 \u03b5\u03af\u03c4\u03b5 \u03cc\u03c7\u03b9, \u03af\u03c3\u03c9\u03c2 \u03c4\u03b1 \u03c3\u03c5\u03bc\u03c0\u03c4\u03ce\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03bd\u03cc\u03c3\u03bf\u03c5 \u03bd\u03ac\u03bd\u03b5 \u03b7\u03c0\u03b9\u03cc\u03c4\u03b5\u03c1\u03b1 \u03b1\u03bb\u03bb\u03ac \u03bc\u03b5\u03c4\u03b1\u03b4\u03af\u03b4\u03b5\u03b9\u03c2 \u03c4\u03bf \u03af\u03b4\u03b9\u03bf \u03c4\u03bf\u03bd Covid-Sars-2"},"content":{"rendered":"<div class=\"panel-pane pane-highwire-article-citation\">\n<div class=\"pane-content\">\n<div id=\"node388976\" class=\"highwire-article-citation highwire-citation-type-highwire-article\" data-node-nid=\"388976\" data-pisa=\"medrxiv;2021.07.31.21261387v1\" data-pisa-master=\"medrxiv;2021.07.31.21261387\" data-apath=\"\/medrxiv\/early\/2021\/07\/31\/2021.07.31.21261387.atom\" data-hw-author-tooltip-instance=\"\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-medrxiv-article-top clearfix has-author-tooltip\">\n<section class=\"article__full-info\">\n<div class=\"article__top-info\">\n<h1 class=\"article__title\">\u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7: \u00ab\u0395\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03b9 \u03ba\u03b1\u03b9 \u03bc\u03b7 \u03ad\u03c7\u03bf\u03c5\u03bd \u03af\u03b4\u03b9\u03bf \u03b9\u03b9\u03ba\u03cc \u03c6\u03bf\u03c1\u03c4\u03af\u03bf &#8211; \u03a0\u03ad\u03c6\u03c4\u03b5\u03b9 \u03b7 \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c3\u03af\u03b1 \u03bc\u03b5\u03c4\u03ac \u03b1\u03c0\u03cc 3 \u03bc\u03ae\u03bd\u03b5\u03c2\u00bb -\u0386\u03c7\u03c1\u03b7\u03c3\u03c4\u03b1 \u03c4\u03b1 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03c4\u03b9\u03ba\u03ac<\/h1>\n<\/div>\n<div class=\"article__summary\">\n<p>\u00ab\u0397 \u0394\u03ad\u03bb\u03c4\u03b1 \u03bc\u03bf\u03bb\u03cd\u03bd\u03b5\u03b9 \u03b5\u03c5\u03ba\u03bf\u03bb\u03cc\u03c4\u03b5\u03c1\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2\u00bb<\/p>\n<\/div>\n<div class=\"article__bottom-info clearfix\">\n<div class=\"article__author-social\">\n<div class=\"article__author\"><\/div>\n<\/div>\n<\/div>\n<\/section>\n<section class=\"main-wrapper has-sidebar clearfix\">\n<div class=\"content-area\">\n<div id=\"body-1011015\" class=\"body\">\n<div class=\"vertical-social fixed\"><\/div>\n<div class=\"field field-name-body field-type-text-with-summary field-label-hidden\">\n<div class=\"field-items\">\n<div class=\"field-item even\">\n<p><strong>\u039d\u03ad\u03b1 \u03bc\u03b5\u03b3\u03ac\u03bb\u03b7 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1 \u03c0\u03bf\u03c5\u00a0\u03b4\u03b9\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae\u03b8\u03b7\u03ba\u03b5 \u03c3\u03c4\u03b7 \u0392\u03c1\u03b5\u03c4\u03b1\u03bd\u03af\u03b1 \u03b1\u03c0\u03cc \u03b5\u03b9\u03b4\u03b9\u03ba\u03bf\u03cd\u03c2 \u03c4\u03bf\u03c5 \u03c0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u03c4\u03b7\u03c2 \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2 \u03b4\u03b5\u03af\u03c7\u03bd\u03b5\u03b9 \u03c0\u03c9\u03c2 \u03b7 \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c3\u03af\u03b1 \u03c0\u03bf\u03c5 \u03c0\u03c1\u03bf\u03c3\u03c6\u03ad\u03c1\u03bf\u03c5\u03bd \u03c4\u03b1 \u03b4\u03cd\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03ba\u03b1\u03c4\u03ac \u03c4\u03b7\u03c2 COVID-19 \u03c0\u03bf\u03c5 \u03b1\u03be\u03b9\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7 \u03c7\u03ce\u03c1\u03b1 \u03b5\u03bd \u03bc\u03ad\u03c3\u03c9 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03c4\u03b1\u03c4\u03c1\u03bf\u03c0\u03ae\u03c2 \u03c4\u03bf\u03c5 \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03c3\u03c4\u03b5\u03bb\u03ad\u03c7\u03bf\u03c5\u03c2 \u0394\u03ad\u03bb\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03bd\u03ad\u03bf\u03c5 \u03ba\u03bf\u03c1\u03c9\u03bd\u03bf\u03ca\u03bf\u03cd \u03c3\u03c4\u03bf \u03ba\u03c5\u03c1\u03af\u03b1\u03c1\u03c7\u03bf \u03bc\u03b5\u03b9\u03ce\u03bd\u03b5\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03b1 \u03c3\u03b5 \u03c4\u03c1\u03b5\u03b9\u03c2 \u03bc\u03ae\u03bd\u03b5\u03c2.<\/strong><\/p>\n<p><strong>\u03a0\u03b1\u03c1\u03ac\u03bb\u03bb\u03b7\u03bb\u03b1 \u03b7 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1 \u03c4\u03bf\u03bd\u03af\u03b6\u03b5\u03b9 \u03c0\u03c9\u03c2 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03b9 \u03c0\u03bf\u03c5 \u03bc\u03bf\u03bb\u03cd\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03bc\u03b5 \u03c4\u03b7 \u03bc\u03b5\u03c4\u03ac\u03bb\u03bb\u03b1\u03be\u03b7 \u0394\u03ad\u03bb\u03c4\u03b1 \u03ad\u03c7\u03bf\u03c5\u03bd\u00a0\u03c0\u03b1\u03c1\u03cc\u03bc\u03bf\u03b9\u03bf \u03b9\u03b9\u03ba\u03cc \u03c6\u03bf\u03c1\u03c4\u03af\u03bf \u03bc\u03b5 \u03c4\u03bf\u03c5\u03c2 \u03bc\u03b7 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2, \u03ba\u03ac\u03c4\u03b9 \u03c0\u03bf\u03c5 \u03b5\u03c0\u03af \u03c4\u03b7\u03c2 \u03bf\u03c5\u03c3\u03af\u03b1\u03c2 \u03ba\u03b1\u03b8\u03b9\u03c3\u03c4\u03ac \u03ac\u03c7\u03c1\u03b7\u03c3\u03c4\u03b1 \u03c4\u03b1 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03c4\u03b9\u03ba\u03ac \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd.\u00a0<\/strong><\/p>\n<p>\u0386\u03bb\u03bb\u03bf \u03ad\u03bd\u03b1 \u03b5\u03cd\u03c1\u03b7\u03bc\u03b1 \u03c4\u03b7\u03c2 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1\u03c2 \u03b1\u03c5\u03c4\u03ae\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c0\u03c9\u03c2 \u03cc\u03c3\u03bf\u03b9 \u03bc\u03bf\u03bb\u03cd\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03bf\u03bd SARS-CoV-2 \u03b1\u03c6\u03bf\u03cd \u03bb\u03ac\u03b2\u03bf\u03c5\u03bd \u03b4\u03cd\u03bf \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03b5\u03af\u03c4\u03b5 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03c4\u03c9\u03bd Pfizer\/BioNTech \u03b5\u03af\u03c4\u03b5 \u03b1\u03c5\u03c4\u03bf\u03cd \u03c4\u03b7\u03c2 AstraZeneca <strong>\u03b5\u03bd\u03b4\u03ad\u03c7\u03b5\u03c4\u03b1\u03b9 \u03bd\u03b1 \u03b4\u03b9\u03b1\u03c4\u03c1\u03ad\u03c7\u03bf\u03c5\u03bd \u03bc\u03b5\u03b3\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03bf \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf \u03b5\u03ac\u03bd \u03bc\u03bf\u03bb\u03c5\u03bd\u03b8\u03bf\u03cd\u03bd \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ae \u0394\u03ad\u03bb\u03c4\u03b1 \u03b1\u03c0\u2019 \u03cc,\u03c4\u03b9 \u03b1\u03c0\u03cc \u03ac\u03bb\u03bb\u03b5\u03c2 \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ad\u03c2.<\/strong><\/p>\n<p>\u0397 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1, \u03c0\u03bf\u03c5 \u03b2\u03b1\u03c3\u03af\u03c3\u03c4\u03b7\u03ba\u03b5 \u03c3\u03b5 <strong>\u03c0\u03ac\u03bd\u03c9 \u03b1\u03c0\u03cc \u03c4\u03c1\u03af\u03b1 \u03b5\u03ba\u03b1\u03c4\u03bf\u03bc\u03bc\u03cd\u03c1\u03b9\u03b1 \u03b4\u03b5\u03af\u03b3\u03bc\u03b1\u03c4\u03b1 <\/strong>\u03c0\u03bf\u03c5 \u03bb\u03ae\u03c6\u03b8\u03b7\u03ba\u03b1\u03bd \u03c3\u03b5 \u03cc\u03bb\u03b7 \u03c4\u03b7\u03bd \u03b5\u03c0\u03b9\u03ba\u03c1\u03ac\u03c4\u03b5\u03b9\u03b1 \u03c4\u03bf\u03c5 \u0397\u03bd\u03c9\u03bc\u03ad\u03bd\u03bf\u03c5 \u0392\u03b1\u03c3\u03b9\u03bb\u03b5\u03af\u03bf\u03c5, \u03ad\u03b4\u03b5\u03b9\u03be\u03b5 \u03c0\u03c9\u03c2 90 \u03b7\u03bc\u03ad\u03c1\u03b5\u03c2 \u03bc\u03b5\u03c4\u03ac \u03c4\u03b7 \u03c7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7\u03c2 \u03b4\u03cc\u03c3\u03b7\u03c2, \u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03bf\u03c5 \u03c4\u03c9\u03bd Pfizer\/BioNTech \u03bc\u03b5\u03b9\u03ce\u03b8\u03b7\u03ba\u03b5 \u03c3\u03c4\u03bf 75% \u03ba\u03b1\u03b9 \u03b1\u03c5\u03c4\u03ae \u03c4\u03bf\u03c5 \u03c3\u03ba\u03b5\u03c5\u03ac\u03c3\u03bc\u03b1\u03c4\u03bf\u03c2 \u03c4\u03b7\u03c2 AstraZeneca \u03c3\u03c4\u03bf 61% \u03c9\u03c2 \u03c0\u03c1\u03bf\u03c2 \u03c4\u03b7\u03bd \u03b1\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03ae \u03c4\u03b7\u03c2 \u03bc\u03cc\u03bb\u03c5\u03bd\u03c3\u03b7\u03c2 \u03b1\u03c0\u03cc \u03c4\u03b7 \u0394\u03ad\u03bb\u03c4\u03b1.<\/p>\n<p><strong>\u03a4\u03b9 \u03ad\u03b4\u03b5\u03b9\u03be\u03b5 \u03b7 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03ba\u03bf\u03c1\u03c9\u03bd\u03bf\u03ca\u03cc<\/strong><\/p>\n<p>\u0394\u03cd\u03bf \u03b5\u03b2\u03b4\u03bf\u03bc\u03ac\u03b4\u03b5\u03c2 \u03bc\u03b5\u03c4\u03ac \u03c4\u03b7 \u03c7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7\u03c2 \u03b4\u03cc\u03c3\u03b7\u03c2, \u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03ac \u03c4\u03bf\u03c5\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b1\u03bd\u03c4\u03af\u03c3\u03c4\u03bf\u03b9\u03c7\u03b1 85% \u03ba\u03b1\u03b9 68%. \u0397 \u03bc\u03b5\u03af\u03c9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c0\u03b9\u03bf \u03c5\u03c8\u03b7\u03bb\u03ae \u03bc\u03b5\u03c4\u03b1\u03be\u03cd \u03c4\u03c9\u03bd \u03c0\u03c1\u03bf\u03c3\u03ce\u03c0\u03c9\u03bd 35 \u03b5\u03c4\u03ce\u03bd \u03ba\u03b1\u03b9 \u03ac\u03bd\u03c9 \u03b1\u03c0\u03cc \u03cc,\u03c4\u03b9 \u03bc\u03b5\u03c4\u03b1\u03be\u03cd \u03c4\u03c9\u03bd \u03b1\u03bd\u03b8\u03c1\u03ce\u03c0\u03c9\u03bd \u03bc\u03b9\u03ba\u03c1\u03cc\u03c4\u03b5\u03c1\u03b7\u03c2 \u03b7\u03bb\u03b9\u03ba\u03af\u03b1\u03c2.<\/p>\n<p><em>\u00ab\u039a\u03b1\u03b9 \u03c4\u03b1 \u03b4\u03cd\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03b1\u03c5\u03c4\u03ac, \u03bc\u03b5\u03c4\u03ac \u03c4\u03b9\u03c2 \u03b4\u03cd\u03bf \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2, \u03c4\u03b1 \u03c0\u03ac\u03bd\u03b5 \u03c0\u03bf\u03bb\u03cd \u03ba\u03b1\u03bb\u03ac \u03ad\u03bd\u03b1\u03bd\u03c4\u03b9 \u03c4\u03b7\u03c2 \u0394\u03ad\u03bb\u03c4\u03b1 (\u2026). \u038c\u03c4\u03b1\u03bd \u03be\u03b5\u03ba\u03b9\u03bd\u03ac\u03c2 \u03c0\u03ac\u03c1\u03b1 \u03c0\u03bf\u03bb\u03cd \u03c8\u03b7\u03bb\u03ac \u03ad\u03c7\u03b5\u03b9\u03c2 \u03b4\u03c1\u03cc\u03bc\u03bf \u03bd\u03b1 \u03b4\u03b9\u03b1\u03bd\u03cd\u03c3\u03b5\u03b9\u03c2\u00bb<\/em>, \u03c3\u03b7\u03bc\u03b5\u03af\u03c9\u03c3\u03b5 \u03b7 \u03a3\u03ac\u03c1\u03b1 \u0393\u03bf\u03c5\u03cc\u03ba\u03b5\u03c1, \u03ba\u03b1\u03b8\u03b7\u03b3\u03ae\u03c4\u03c1\u03b9\u03b1 \u03c3\u03c4\u03b7\u03bd \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7 \u03b5\u03b9\u03b4\u03b9\u03ba\u03b5\u03c5\u03bc\u03ad\u03bd\u03b7 \u03c3\u03c4\u03b7\u03bd \u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u03c3\u03c4\u03b1\u03c4\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03ba\u03b1\u03b9 \u03b5\u03c0\u03b9\u03ba\u03b5\u03c6\u03b1\u03bb\u03ae\u03c2 \u03c4\u03b7\u03c2 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1\u03c2 \u03c0\u03bf\u03c5 \u03b4\u03b9\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae\u03b8\u03b7\u03ba\u03b5.<\/p>\n<p>\u0397 \u0393\u03bf\u03c5\u03cc\u03ba\u03b5\u03c1 \u03b4\u03b5\u03bd \u03c3\u03c5\u03bc\u03bc\u03b5\u03c4\u03b5\u03af\u03c7\u03b5 \u03c3\u03c4\u03bf \u03c3\u03ba\u03ad\u03bb\u03bf\u03c2 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03bf \u03c4\u03b7\u03c2 AstraZeneca, \u03ba\u03b1\u03b8\u03ce\u03c2 \u03c4\u03bf \u03c3\u03ba\u03b5\u03cd\u03b1\u03c3\u03bc\u03b1 \u03b1\u03c5\u03c4\u03cc \u03b1\u03bd\u03b1\u03c0\u03c4\u03cd\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc \u03b1\u03bd\u03bf\u03c3\u03bf\u03bb\u03cc\u03b3\u03bf\u03c5\u03c2 \u03c4\u03bf\u03c5 \u03c0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u03c4\u03b7\u03c2 \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2.<\/p>\n<p>\u038c\u03c0\u03c9\u03c2 \u03b1\u03bd\u03b1\u03c6\u03ad\u03c1\u03b5\u03c4\u03b1\u03b9 \u03c3\u03c4\u03bf \u0391\u03a0\u0395-\u039c\u03a0\u0395, \u03bf\u03b9 \u03c3\u03c5\u03bd\u03c4\u03ac\u03ba\u03c4\u03b5\u03c2 \u03c4\u03b7\u03c2 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1\u03c2 \u03b1\u03c0\u03ad\u03c6\u03c5\u03b3\u03b1\u03bd \u03bd\u03b1 \u03ba\u03ac\u03bd\u03bf\u03c5\u03bd \u03c0\u03c1\u03bf\u03b2\u03bb\u03ad\u03c8\u03b5\u03b9\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c0\u03b5\u03c1\u03b1\u03b9\u03c4\u03ad\u03c1\u03c9 \u03bc\u03b5\u03af\u03c9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03c9\u03bd \u03b4\u03cd\u03bf \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03b5\u03bd \u03ba\u03b1\u03b9\u03c1\u03ce, \u03c9\u03c3\u03c4\u03cc\u03c3\u03bf \u03b5\u03ba\u03c4\u03af\u03bc\u03b7\u03c3\u03b1\u03bd \u03c0\u03c9\u03c2 <strong>\u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03ac \u03c4\u03bf\u03c5\u03c2 \u03b8\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9 \u03c7\u03bf\u03bd\u03b4\u03c1\u03b9\u03ba\u03ac \u03c0\u03b1\u03c1\u03cc\u03bc\u03bf\u03b9\u03b1 4-5 \u03bc\u03ae\u03bd\u03b5\u03c2 \u03bc\u03b5\u03c4\u03ac \u03c4\u03b7 \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03b7 \u03b4\u03cc\u03c3\u03b7.<\/strong><\/p>\n<p><strong>\u0399\u03b9\u03ba\u03cc \u03c6\u03bf\u03c1\u03c4\u03af\u03bf<\/strong><\/p>\n<p><strong>\u03a5\u03c0\u03bf\u03b3\u03c1\u03b1\u03bc\u03bc\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03c2 \u03c4\u03bf\u03bd \u03b1\u03c5\u03be\u03b7\u03bc\u03ad\u03bd\u03bf \u03ba\u03af\u03bd\u03b4\u03c5\u03bd\u03bf \u03c0\u03bf\u03c5 \u03b5\u03bd\u03ad\u03c7\u03b5\u03b9 \u03b7 \u03bc\u03cc\u03bb\u03c5\u03bd\u03c3\u03b7 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ae \u0394\u03ad\u03bb\u03c4\u03b1, \u03bf\u03b9 \u03b5\u03c1\u03b5\u03c5\u03bd\u03b7\u03c4\u03ad\u03c2 \u03c3\u03b7\u03bc\u03b5\u03af\u03c9\u03c3\u03b1\u03bd \u03c0\u03c9\u03c2 \u03cc\u03c3\u03bf\u03b9 \u03bc\u03bf\u03bb\u03cd\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03c1\u03cc\u03c4\u03b9 \u03ad\u03c7\u03bf\u03c5\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03c4\u03b5\u03af \u03c0\u03bb\u03ae\u03c1\u03c9\u03c2 \u03c4\u03b5\u03af\u03bd\u03bf\u03c5\u03bd \u03bd\u03b1 \u03ad\u03c7\u03bf\u03c5\u03bd \u03b9\u03b9\u03ba\u03cc \u03c6\u03bf\u03c1\u03c4\u03af\u03bf \u03c0\u03b1\u03c1\u03cc\u03bc\u03bf\u03b9\u03bf \u03bc\u03b5 \u03c4\u03bf\u03c5\u03c2 \u03b1\u03bd\u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03b1\u03c3\u03c4\u03bf\u03c5\u03c2 \u2014 \u03b1\u03bd\u03c4\u03af\u03b8\u03b5\u03c4\u03b1 \u03bc\u03b5 \u03cc,\u03c4\u03b9 \u03c3\u03c5\u03bd\u03ad\u03b2\u03b1\u03b9\u03bd\u03b5 \u03cc\u03c4\u03b1\u03bd \u03ba\u03c5\u03c1\u03af\u03b1\u03c1\u03c7\u03b7 \u03ae\u03c4\u03b1\u03bd \u03b1\u03ba\u03cc\u03bc\u03b7 \u03b7 \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ae \u0386\u03bb\u03c6\u03b1.<\/strong><\/p>\n<p>\u03a4\u03b1 \u03b5\u03c5\u03c1\u03ae\u03bc\u03b1\u03c4\u03b1 \u03c4\u03c9\u03bd \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03cc\u03bd\u03c9\u03bd \u03c4\u03bf\u03c5 \u03c0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u03c4\u03b7\u03c2 \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2 \u03b3\u03b5\u03bd\u03b9\u03ba\u03ac \u03c3\u03c5\u03bd\u03ac\u03b4\u03b5\u03b9 \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b1\u03bd\u03ac\u03bb\u03c5\u03c3\u03b7 \u03c4\u03c9\u03bd \u039a\u03ad\u03bd\u03c4\u03c1\u03c9\u03bd \u0395\u03bb\u03ad\u03b3\u03c7\u03bf\u03c5 \u03ba\u03b1\u03b9 \u03a0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7\u03c2 \u0391\u03c3\u03b8\u03b5\u03bd\u03b5\u03b9\u03ce\u03bd (CDC), \u03c4\u03b7\u03c2 \u03ba\u03c5\u03c1\u03b9\u03cc\u03c4\u03b5\u03c1\u03b7\u03c2 \u03bf\u03bc\u03bf\u03c3\u03c0\u03bf\u03bd\u03b4\u03b9\u03b1\u03ba\u03ae\u03c2 \u03c5\u03c0\u03b7\u03c1\u03b5\u03c3\u03af\u03b1\u03c2 \u03b4\u03b7\u03bc\u03cc\u03c3\u03b9\u03b1\u03c2 \u03c5\u03b3\u03b5\u03af\u03b1\u03c2 \u03c4\u03c9\u03bd \u0397\u03a0\u0391, \u03ba\u03b1\u03b9 \u03b4\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03b7\u03bd \u03ce\u03c1\u03b1 \u03c0\u03bf\u03c5 \u03b7 \u039f\u03c5\u03ac\u03c3\u03b9\u03bd\u03b3\u03ba\u03c4\u03bf\u03bd \u03b1\u03bd\u03ae\u03b3\u03b3\u03b5\u03b9\u03bb\u03b5 \u03c0\u03c9\u03c2 \u03b8\u03b1 \u03b1\u03c1\u03c7\u03af\u03c3\u03bf\u03c5\u03bd \u03bd\u03b1 \u03c7\u03bf\u03c1\u03b7\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03c4\u03bf\u03bd \u03a3\u03b5\u03c0\u03c4\u03ad\u03bc\u03b2\u03c1\u03b9\u03bf \u03c4\u03c1\u03af\u03c4\u03b5\u03c2, \u03b1\u03bd\u03b1\u03bc\u03bd\u03b7\u03c3\u03c4\u03b9\u03ba\u03ad\u03c2 \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03c4\u03c9\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03af\u03c9\u03bd \u03b5\u03be\u03b1\u03b9\u03c4\u03af\u03b1\u03c2 \u03c4\u03b7\u03c2 \u03b1\u03cd\u03be\u03b7\u03c3\u03b7\u03c2 \u03c4\u03c9\u03bd \u03bc\u03bf\u03bb\u03cd\u03bd\u03c3\u03b5\u03c9\u03bd \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ae \u0394\u03ad\u03bb\u03c4\u03b1. <strong>\u0397 \u03ba\u03c5\u03b2\u03ad\u03c1\u03bd\u03b7\u03c3\u03b7 \u03c4\u03bf\u03c5 \u03a4\u03b6\u03bf \u039c\u03c0\u03ac\u03b9\u03bd\u03c4\u03b5\u03bd \u03b5\u03c0\u03b9\u03ba\u03b1\u03bb\u03ad\u03c3\u03c4\u03b7\u03ba\u03b5 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03b1 \u03c0\u03bf\u03c5 \u03c5\u03c0\u03bf\u03b4\u03b5\u03b9\u03ba\u03bd\u03cd\u03bf\u03c5\u03bd \u03cc\u03c4\u03b9 \u03b7 \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c3\u03af\u03b1 \u03c0\u03bf\u03c5 \u03c0\u03c1\u03bf\u03c3\u03c6\u03ad\u03c1\u03bf\u03c5\u03bd \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03bc\u03b5\u03b9\u03ce\u03bd\u03b5\u03c4\u03b1\u03b9 \u03b5\u03bd \u03ba\u03b1\u03b9\u03c1\u03ce.<\/strong><\/p>\n<p>\u03a4\u03bf \u0399\u03c3\u03c1\u03b1\u03ae\u03bb \u03ac\u03c1\u03c7\u03b9\u03c3\u03b5 \u03bd\u03b1 \u03c7\u03bf\u03c1\u03b7\u03b3\u03b5\u03af \u03c4\u03c1\u03af\u03c4\u03b5\u03c2 \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03c4\u03bf\u03bd \u03c0\u03b5\u03c1\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf \u03bc\u03ae\u03bd\u03b1, \u03b3\u03b9\u03b1 \u03bd\u03b1 \u03b8\u03ad\u03c3\u03b5\u03b9 \u03c5\u03c0\u03cc \u03ad\u03bb\u03b5\u03b3\u03c7\u03bf \u03c4\u03b7\u03bd \u03ad\u03be\u03b1\u03c1\u03c3\u03b7 \u03c4\u03c9\u03bd \u03bc\u03bf\u03bb\u03cd\u03bd\u03c3\u03b5\u03c9\u03bd \u03c0\u03bf\u03c5 \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03b1\u03c0\u03bf\u03b4\u03af\u03b4\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7 \u0394\u03ad\u03bb\u03c4\u03b1. \u0391\u03c1\u03ba\u03b5\u03c4\u03ad\u03c2 \u03b5\u03c5\u03c1\u03c9\u03c0\u03b1\u03ca\u03ba\u03ad\u03c2 \u03c7\u03ce\u03c1\u03b5\u03c2 \u03b1\u03bd\u03b1\u03bc\u03ad\u03bd\u03b5\u03c4\u03b1\u03b9 \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03bd\u03b1 \u03b1\u03c1\u03c7\u03af\u03c3\u03bf\u03c5\u03bd \u03bd\u03b1 \u03c7\u03bf\u03c1\u03b7\u03b3\u03bf\u03cd\u03bd \u03b1\u03bd\u03b1\u03bc\u03bd\u03b7\u03c3\u03c4\u03b9\u03ba\u03ad\u03c2 \u03b4\u03cc\u03c3\u03b5\u03b9\u03c2 \u03c3\u03b5 \u03b7\u03bb\u03b9\u03ba\u03b9\u03c9\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03bd\u03b8\u03c1\u03ce\u03c0\u03bf\u03c5\u03c2 \u03bc\u03b5 \u03b5\u03be\u03b1\u03c3\u03b8\u03b5\u03bd\u03b7\u03bc\u03ad\u03bd\u03bf \u03b1\u03bd\u03bf\u03c3\u03bf\u03c0\u03bf\u03b9\u03b7\u03c4\u03b9\u03ba\u03cc \u03c3\u03cd\u03c3\u03c4\u03b7\u03bc\u03b1.<\/p>\n<p>\u0397 Pfizer \u03b1\u03bd\u03b1\u03b3\u03bd\u03c9\u03c1\u03af\u03b6\u03b5\u03b9 \u03cc\u03c4\u03b9 \u03b7 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 \u03c3\u03ba\u03b5\u03c5\u03ac\u03c3\u03bc\u03b1\u03c4\u03cc\u03c2 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03b9\u03ce\u03bd\u03b5\u03c4\u03b1\u03b9 \u03bc\u03b5 \u03c4\u03bf\u03bd \u03ba\u03b1\u03b9\u03c1\u03cc. \u03a4\u03bf\u03bd \u03c0\u03b5\u03c1\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf \u03bc\u03ae\u03bd\u03b1, \u03b7 AstraZeneca \u03b1\u03bd\u03ad\u03c6\u03b5\u03c1\u03b5 \u03c0\u03c9\u03c2 \u03b1\u03ba\u03cc\u03bc\u03b7 \u03bc\u03b5\u03bb\u03b5\u03c4\u03ac \u03c0\u03cc\u03c3\u03bf \u03b4\u03b9\u03b1\u03c1\u03ba\u03b5\u03af \u03b7 \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c3\u03af\u03b1 \u03c4\u03bf\u03c5 \u03b4\u03b9\u03ba\u03bf\u03cd \u03c4\u03b7\u03c2 \u03c3\u03ba\u03b5\u03c5\u03ac\u03c3\u03bc\u03b1\u03c4\u03bf\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03bd \u03c7\u03c1\u03b5\u03b9\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03b1\u03bd\u03b1\u03bc\u03bd\u03b7\u03c3\u03c4\u03b9\u03ba\u03ae \u03b4\u03cc\u03c3\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03b7 \u03b4\u03b9\u03b1\u03c4\u03ae\u03c1\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03bd\u03bf\u03c3\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7\u03c2.<\/p>\n<p><strong><em>\u00ab\u03a4\u03bf \u03b3\u03b5\u03b3\u03bf\u03bd\u03cc\u03c2 \u03c0\u03c9\u03c2 \u03b2\u03bb\u03ad\u03c0\u03bf\u03c5\u03bc\u03b5 (\u2026) \u03c5\u03c8\u03b7\u03bb\u03cc\u03c4\u03b5\u03c1\u03b1 \u03b9\u03b9\u03ba\u03ac \u03c6\u03bf\u03c1\u03c4\u03af\u03b1 \u03c5\u03c0\u03bf\u03b4\u03b5\u03b9\u03ba\u03bd\u03cd\u03b5\u03b9 (\u2026) \u03c0\u03c9\u03c2 \u03c0\u03c1\u03ac\u03b3\u03bc\u03b1\u03c4\u03b9 \u03b7 \u03b5\u03c0\u03af\u03c4\u03b5\u03c5\u03be\u03b7 \u03c3\u03c5\u03bb\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae\u03c2 \u03b1\u03bd\u03bf\u03c3\u03af\u03b1\u03c2 \u03b5\u03bd\u03b4\u03ad\u03c7\u03b5\u03c4\u03b1\u03b9 \u03bd\u03b1 \u03b1\u03c0\u03bf\u03b4\u03b5\u03b9\u03c7\u03b8\u03b5\u03af \u03bc\u03b5\u03b3\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03b7 \u03c0\u03c1\u03cc\u03ba\u03bb\u03b7\u03c3\u03b7\u00bb <\/em><\/strong>\u03b1\u03c0\u03cc \u03cc,\u03c4\u03b9 \u03b8\u03b5\u03c9\u03c1\u03b5\u03af\u03c4\u03bf \u03bc\u03ad\u03c7\u03c1\u03b9 \u03c4\u03ce\u03c1\u03b1, \u03c3\u03cd\u03bc\u03c6\u03c9\u03bd\u03b1 \u03bc\u03b5 \u03c4\u03bf\u03bd \u039a\u03bf\u03c5\u03bd \u03a0\u03ac\u03bf\u03c5\u03bb\u03c2, \u03c0\u03bf\u03c5 \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03b5\u03c1\u03b3\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \u03c3\u03c4\u03bf \u03c0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03ae\u03bc\u03b9\u03bf \u03c4\u03b7\u03c2 \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2.<\/p>\n<p><strong>\u03a6\u03b1\u03af\u03bd\u03b5\u03c4\u03b1\u03b9 \u03c0\u03c9\u03c2 \u03c4\u03b1 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03b5\u03af\u03bd\u03b1\u03b9 \u03ba\u03b1\u03bb\u03cd\u03c4\u03b5\u03c1\u03b1 \u03c3\u03c4\u03b7\u03bd \u03b1\u03c0\u03bf\u03c4\u03c1\u03bf\u03c0\u03ae \u03c3\u03bf\u03b2\u03b1\u03c1\u03ce\u03bd \u03bc\u03bf\u03c1\u03c6\u03ce\u03bd \u03c4\u03b7\u03c2 \u03b1\u03c3\u03b8\u03ad\u03bd\u03b5\u03b9\u03b5\u03c2 \u03ba\u03b1\u03b9 \u03bb\u03b9\u03b3\u03cc\u03c4\u03b5\u03c1\u03bf \u00ab\u03c3\u03c4\u03b7\u03bd \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7 \u03c4\u03b7\u03c2 \u03bc\u03b5\u03c4\u03ac\u03b4\u03bf\u03c3\u03b7\u03c2\u00bb, \u03ba\u03b1\u03c4\u03ac \u03c4\u03bf\u03bd \u03af\u03b4\u03b9\u03bf. (\u03a3.\u03b3.: \u039a\u03b1\u03bd\u03b5\u03af\u03c2 \u03cc\u03bc\u03c9\u03c2 \u03b4\u03b5\u03bd \u03c3\u03bf\u03c5 \u03b5\u03b3\u03b3\u03c5\u03ac\u03c4\u03b1\u03b9 \u03cc\u03c4\u03b9 \u03b4\u03b5\u03bd \u03b8\u03b1 \u03c0\u03ac\u03b8\u03b5\u03b9\u03c2 \u03ba\u03ac\u03c0\u03bf\u03b9\u03b1 \u03c0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b1 \u03b1\u03c0\u03cc \u03c4\u03b1 \u03b4\u03c5\u03bf \u03c9\u03c2 \u03ac\u03bd\u03c9 \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03bf\u03c4\u03b1\u03bd \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03c4\u03b5\u03af\u03c2).<br \/>\n<\/strong><\/p>\n<p>\u0397 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1 \u03b1\u03c5\u03c4\u03ae, \u03c0\u03bf\u03c5 \u03b1\u03ba\u03cc\u03bc\u03b7 \u03bc\u03ad\u03bd\u03b5\u03b9 \u03bd\u03b1 \u03c5\u03c0\u03bf\u03b2\u03bb\u03b7\u03b8\u03b5\u03af \u03c3\u03b5 \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03b1\u03c0\u03cc \u03bf\u03bc\u03cc\u03c4\u03b9\u03bc\u03bf\u03c5\u03c2 \u03ba\u03b1\u03b9 \u03bd\u03b1 \u03b4\u03b7\u03bc\u03bf\u03c3\u03b9\u03b5\u03c5\u03b8\u03b5\u03af \u03c3\u03b5 \u03ba\u03ac\u03c0\u03bf\u03b9\u03b1 \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03bf\u03bd\u03b9\u03ba\u03ae \u03b5\u03c0\u03b9\u03b8\u03b5\u03ce\u03c1\u03b7\u03c3\u03b7, \u03bc\u03bf\u03b9\u03ac\u03b6\u03b5\u03b9 \u03bd\u03b1 \u03b5\u03c0\u03b9\u03b2\u03b5\u03b2\u03b1\u03b9\u03ce\u03bd\u03b5\u03b9 \u03ba\u03b1\u03b9 \u03bd\u03b1 \u03c5\u03c0\u03bf\u03b3\u03c1\u03b1\u03bc\u03bc\u03af\u03b6\u03b5\u03b9 \u03c4\u03b7\u03bd \u03b1\u03bd\u03b7\u03c3\u03c5\u03c7\u03af\u03b1 \u03c4\u03c9\u03bd \u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03cc\u03bd\u03c9\u03bd \u03c0\u03c9\u03c2 <strong>\u03b7 \u03c0\u03b1\u03c1\u03b1\u03bb\u03bb\u03b1\u03b3\u03ae \u0394\u03ad\u03bb\u03c4\u03b1, \u03b7 \u03bf\u03c0\u03bf\u03af\u03b1 \u03b1\u03c1\u03c7\u03b9\u03ba\u03ac \u03c4\u03b1\u03c5\u03c4\u03bf\u03c0\u03bf\u03b9\u03ae\u03b8\u03b7\u03ba\u03b5 \u03c3\u03c4\u03b7\u03bd \u0399\u03bd\u03b4\u03af\u03b1, \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03bc\u03bf\u03bb\u03cd\u03bd\u03b5\u03b9 \u03c0\u03bb\u03ae\u03c1\u03c9\u03c2 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2 \u03b1\u03bd\u03b8\u03c1\u03ce\u03c0\u03bf\u03c5\u03c2 \u03ba\u03b1\u03b9 \u03b4\u03b7 \u03b5\u03c5\u03ba\u03bf\u03bb\u03cc\u03c4\u03b5\u03c1\u03b1.<\/strong><\/p>\n<p>\u0397 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1 \u03c4\u03bf\u03c5 \u03c0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u03c4\u03b7\u03c2 \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2 \u03b4\u03b9\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae\u03b8\u03b7\u03ba\u03b5 \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b5\u03c1\u03b3\u03b1\u03c3\u03af\u03b1 \u03bc\u03b5 \u03c4\u03b7 \u03b2\u03c1\u03b5\u03c4\u03b1\u03bd\u03b9\u03ba\u03ae \u03b5\u03b8\u03bd\u03b9\u03ba\u03ae \u03c3\u03c4\u03b1\u03c4\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae \u03c5\u03c0\u03b7\u03c1\u03b5\u03c3\u03af\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03bf \u03c5\u03c0\u03bf\u03c5\u03c1\u03b3\u03b5\u03af\u03bf \u03a5\u03b3\u03b5\u03af\u03b1\u03c2 \u03ba\u03b1\u03b9 \u039a\u03bf\u03b9\u03bd\u03c9\u03bd\u03b9\u03ba\u03ae\u03c2 \u03a0\u03c1\u03cc\u03bd\u03bf\u03b9\u03b1\u03c2 \u03c4\u03b7\u03c2 \u0392\u03c1\u03b5\u03c4\u03b1\u03bd\u03af\u03b1\u03c2.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"pronews-like clearfix\"><img decoding=\"async\" src=\"https:\/\/www.pronews.gr\/sites\/all\/themes\/pronews\/images\/pronews-logo-white.svg\" alt=\"Pronews\" \/><\/div>\n<\/div>\n<\/section>\n<h1 id=\"page-title\" class=\"highwire-cite-title\">Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant<\/h1>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\"><span class=\"highwire-citation-author first has-tooltip hasTooltip\" data-delta=\"0\" data-hasqtip=\"5\"><span class=\"nlm-given-names\">Kasen K.<\/span> <span class=\"nlm-surname\">Riemersma<\/span><\/span>, <span class=\"highwire-citation-author has-tooltip hasTooltip\" data-delta=\"1\" data-hasqtip=\"1\"><span class=\"nlm-given-names\">Brittany E.<\/span> <span class=\"nlm-surname\">Grogan<\/span><\/span>, <span class=\"highwire-citation-author has-tooltip hasTooltip\" data-delta=\"2\" data-hasqtip=\"3\"><span class=\"nlm-given-names\">Amanda<\/span> <span class=\"nlm-surname\">Kita-Yarbro<\/span><\/span>, <span class=\"highwire-citation-author has-tooltip hasTooltip\" data-delta=\"3\" data-hasqtip=\"2\"><span class=\"nlm-given-names\">Gunnar E.<\/span> <span class=\"nlm-surname\">Jeppson<\/span><\/span>, <span class=\"highwire-citation-author\" data-delta=\"4\"><span class=\"nlm-given-names\">David H.<\/span> <span class=\"nlm-surname\">O\u2019Connor<\/span><\/span>, <span class=\"highwire-citation-author hw-author-orcid-logo-wrapper has-tooltip hasTooltip\" data-delta=\"5\" data-hasqtip=\"4\" aria-describedby=\"qtip-4\"><a class=\"hw-author-orcid-logo link-icon-only link-icon\" href=\"http:\/\/orcid.org\/0000-0001-9831-6895\" target=\"_blank\" rel=\"noopener\"> <span class=\"title element-invisible\">View ORCID Profile<\/span><\/a><span class=\"nlm-given-names\">Thomas C.<\/span> <span class=\"nlm-surname\">Friedrich<\/span><\/span>, <span class=\"highwire-citation-author has-tooltip hasTooltip\" data-delta=\"6\" data-hasqtip=\"0\"><span class=\"nlm-given-names\">Katarina M.<\/span> <span class=\"nlm-surname\">Grande<\/span><\/span><\/span><\/div>\n<div class=\"highwire-cite-metadata\">\n<p><span class=\"highwire-cite-metadata-doi highwire-cite-metadata\"><span class=\"label\">doi:<\/span> https:\/\/doi.org\/10.1101\/2021.07.31.21261387 <\/span><\/p>\n<div class=\"pub_jnl\"><a href=\"https:\/\/www.medrxiv.org\/content\/what-unrefereed-preprint\" target=\"_blank\" rel=\"noopener\">This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should <em>not<\/em> be used to guide clinical practice.<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs panels-ajax-tabs-once-processed\">\n<div class=\"pane-content\">\n<div class=\"item-list\"><\/div>\n<\/div>\n<\/div>\n<div class=\"panel-pane pane-highwire-panel-tabs-container\">\n<div class=\"pane-content\">\n<div id=\"panels-ajax-tab-container-highwire_article_tabs\" class=\"panels-ajax-tab-container\" data-panels-ajax-tab-preloaded=\"biorxiv_tab_art\">\n<div class=\"panels-ajax-tab-wrap-biorxiv_tab_art\">\n<div class=\"panel-display panel-1col clearfix\">\n<div class=\"panel-panel panel-col\">\n<div>\n<div class=\"panel-pane pane-highwire-markup\">\n<div class=\"pane-content\">\n<div class=\"highwire-markup\">\n<div id=\"content-block-markup\" data-highwire-cite-ref-tooltip-instance=\"highwire_reflinks_tooltip\">\n<div class=\"article abstract-view \">\n<div id=\"abstract-1\" class=\"section abstract\">\n<h2 class=\"\">Abstract<\/h2>\n<p id=\"p-2\">SARS-CoV-2 variant B.1.617.2 (delta) is associated with higher viral loads [<a id=\"xref-ref-1-1\" class=\"xref-bibr hw-no-refrence\" href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2021.07.31.21261387v1#ref-1\">1<\/a>] and increased transmissibility relative to other variants, as well as partial escape from polyclonal and monoclonal antibodies [<a id=\"xref-ref-2-1\" class=\"xref-bibr\" href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2021.07.31.21261387v1#ref-2\">2<\/a>]. The emergence of the delta variant has been associated with increasing case counts and test-positivity rates, indicative of rapid community spread. Since early July 2021, SARS-CoV-2 cases in the United States have increased coincident with delta SARS-CoV-2 becoming the predominant lineage nationwide [<a id=\"xref-ref-3-1\" class=\"xref-bibr\" href=\"https:\/\/www.medrxiv.org\/content\/10.1101\/2021.07.31.21261387v1#ref-3\">3<\/a>]. Understanding how and why the virus is spreading in settings where there is high vaccine coverage has important public health implications.<strong> It is particularly important to assess whether vaccinated individuals who become infected can transmit SARS-CoV-2 to others.<\/strong> In Wisconsin, a large local contract laboratory provides SARS-CoV-2 testing for multiple local health departments, providing a single standard source of data using the same assay to measure virus burdens in test-positive cases. This includes providing high-volume testing in Dane County, a county with extremely high vaccine coverage. These PCR-based tests provide semi-quantitative information about the viral load, or amount of SARS-CoV-2 RNA, in respiratory specimens. Here we use this viral load data to compare the amount of SARS-CoV-2 present in test-positive specimens from people who self-report their vaccine status and date of final immunization, during a period in which the delta variant became the predominant circulating variant in Wisconsin.<strong> We find no difference in viral loads when comparing unvaccinated individuals to those who have vaccine \u201cbreakthrough\u201d infections.<\/strong> Furthermore, individuals with vaccine breakthrough infections frequently test positive with viral loads consistent with the ability to shed infectious viruses. Our results, while preliminary, suggest that if vaccinated individuals become infected with the delta variant, they may be sources of SARS-CoV-2 transmission to others.<\/p>\n<\/div>\n<h3>Competing Interest Statement<\/h3>\n<p id=\"p-3\">The authors have declared no competing interest.<\/p>\n<h3>Funding Statement<\/h3>\n<p id=\"p-4\">This work was supported by Centers for Disease Control and Prevention contracts 75D30120C09870 and 75D30121C11060 to D.H.O and T.C.F. The authors are also members of the Upper Midwest Regional Accelerator for Genomic Surveillance funded by <strong>the Rockefeller Foundation.<\/strong><\/p>\n<h3>Author Declarations<\/h3>\n<p id=\"p-5\">I confirm all relevant ethical guidelines have been followed, and any necessary IRB and\/or ethics committee approvals have been obtained.<\/p>\n<p id=\"p-6\">Yes<\/p>\n<p id=\"p-7\">The details of the IRB\/oversight body that provided approval or exemption for the research described are given below:<\/p>\n<p id=\"p-8\">The University of Wisconsin-Madison IRB office has confirmed that this project qualifies as public health surveillance activities as defined in the Common Rule, 45 CFR 46.102(l)(2). As such, the project is not deemed to be research regulated under the Common Rule and therefore, does not require University of Wisconsin-Madison IRB review and oversight.<\/p>\n<p id=\"p-9\">All necessary patient\/participant consent has been obtained and the appropriate institutional forms have been archived.<\/p>\n<p id=\"p-10\">Yes<\/p>\n<p id=\"p-11\">I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).<\/p>\n<p id=\"p-12\">Yes<\/p>\n<p id=\"p-13\">I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.<\/p>\n<p id=\"p-14\">Yes<\/p>\n<p>Paper in collection <b><a href=\"http:\/\/connect.medrxiv.org\/relate\/content\/181\">COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv<\/a><\/b><\/p>\n<p>Source:https:\/\/www.medrxiv.org\/content\/10.1101\/2021.07.31.21261387v1<\/p>\n<h1 id=\"page-title\" class=\"title\">\u0392\u03b9\u03b2\u03bb\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03ad\u03c2 \u0391\u03bd\u03b1\u03c6\u03bf\u03c1\u03ad\u03c2, Papers on COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv<\/h1>\n<div id=\"block-system-main\" class=\"main-content-wrapper grid-17 suffix-1 alpha\">\n<p>18,277 Articles (14,070 medRxiv, 4,207 bioRxiv)<\/p>\n<p class=\"collection_clear\">Most recent first Page 1:\u00a0Articles 1-10 \u00a0|\u00a0<a href=\"http:\/\/connect.medrxiv.org\/relate\/content\/181?page=2\">Next <i class=\"icon-circle-arrow-right\"><\/i><\/a><\/p>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Cap-independent translation and a precisely localized RNA sequence enable SARS-CoV-2 to control host translation and escape anti-viral response\" href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.18.456855\" target=\"_blank\" rel=\"noopener\">Cap-independent translation and a precisely localized RNA sequence enable SARS-CoV-2 to control host translation and escape anti-viral response<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Slobodin, B., Sehrawat, U., Lev, A., Ogran, A., Fraticelli, D., Hayat, D., Zuckerman, B., Ulitsky, I., Ben-Shmuel, A., Levy, H., Bar-David, E., Dikstein, R.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.18.456855\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.18.456855<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Interaction between spike protein of SARS-CoV-2 and human virus receptor ACE2 using two-color fluorescence cross-correlation spectroscopy\" href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.18.456769\" target=\"_blank\" rel=\"noopener\">Interaction between spike protein of SARS-CoV-2 and human virus receptor ACE2 using two-color fluorescence cross-correlation spectroscopy<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Fujimoto, A., Lyu, Y., Kinjo, M., Kitamura, A.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.18.456769\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.18.456769<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Protein-based RBD-C-tag COVID-19 Vaccination Candidate Elicits Protection Activity against SARS-COV-2 Variant Infection\" href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.17.456704\" target=\"_blank\" rel=\"noopener\">Protein-based RBD-C-tag COVID-19 Vaccination Candidate Elicits Protection Activity against SARS-COV-2 Variant Infection<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Herrmann, A., Subramani, J., Shaabani, N., Shetty, D., Wu, H., Kwon, S., Li, W., Yue, C., Lahtz, C., Ramirez-Torres, A., Zhou, H., Zhang, Y., Allen, R. D., Farley, B., Emalfarb, M., Tchelet, R., Markku, S., Marika, V., Wiebe, M., Huuskonen, A., Ben-artzi, H., Avigdor, A., Ji, H.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.17.456704\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.17.456704<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"An Endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells\" href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.17.456707\" target=\"_blank\" rel=\"noopener\">An Endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Broadbent, L., Bamford, C. G. G., Lopez Campos, G., Manzoor, S., Courtney, D., Ali, A., Touzelet, O., McCaughey, C., Mills, K., Power, U.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/biorxiv.org\/cgi\/content\/short\/2021.08.17.456707\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.17.456707<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Proactive COVID-19 testing in a partially vaccinated population\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262095\" target=\"_blank\" rel=\"noopener\">Proactive COVID-19 testing in a partially vaccinated population<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">McGee, R. S., Homburger, J. R., Williams, H. E., Bergstrom, C. T., Zhou, A. Y.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262095\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.15.21262095<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262121\" target=\"_blank\" rel=\"noopener\">Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">McLean, H. Q., Grijalva, C. G., Hanson, K. E., Zhu, Y., Deyoe, J. E., Meece, J. K., Halasa, N. B., Chappell, J. D., Mellis, A., Reed, C., Belongia, E. A., Talbot, H. K., Rolfes, M. A.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262121\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.16.21262121<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262128\" target=\"_blank\" rel=\"noopener\">Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Horspool, A. M., Russ, B. P., Wolf, M. A., Kang, J., Blackwood, C. B., Hall, J. M., Wong, T. Y., DeJong, M. A., Bitzer, G., Bevere, J. R., Eggleston, R., Stewart, A., Costello, L., Welch, S., Kieffer, T., Hodder, S., Damron, F. H.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262128\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.16.21262128<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Point of emission air filtration enhances protection of health care workers against skin contamination with virus aerosol\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21261997\" target=\"_blank\" rel=\"noopener\">Point of emission air filtration enhances protection of health care workers against skin contamination with virus aerosol<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Landry, S. A., Subedi, D., MacDonald, M. I., Dix, S., Kutey, D., Barr, J., Mansfield, D., Hamilton, G., Edwards, B., Joosten, S.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21261997\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.15.21261997<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity?\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21261584\" target=\"_blank\" rel=\"noopener\">A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity?<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Sughayer, M. A., Mansour, A., Al Nuirat, A., Souan, L., Abdel-Razeq, R., Siag, M.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21261584\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.15.21261584<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Dynamics of seroconversion of anti-SARS-CoV-2 IgG antibodies in the Czech unvaccinated population: nationwide prospective seroconversion (PROSECO) study\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262007\" target=\"_blank\" rel=\"noopener\">Dynamics of seroconversion of anti-SARS-CoV-2 IgG antibodies in the Czech unvaccinated population: nationwide prospective seroconversion (PROSECO) study<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Piler, P., Thon, V., Andryskova, L., Dolezel, K., Kostka, D., Pavlik, T., Dusek, L., Pikhart, H., Bobak, M., Klanova, J.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262007\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.15.21262007<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"><a class=\"highwire-cite-linked-title\" title=\"COVID-19 infection, hospitalisation and death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project.\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.17.21260846\" target=\"_blank\" rel=\"noopener\">OVID-19 infection, hospitalisation and death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project.<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Rutter, M., Lanyon, P. C., Grainge, M. J., Hubbard, R., Peach, E., Bythell, M., Stilwell, P., Ashton, J., Stevens, S., Pearce, F. A.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.17.21260846\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.17.21260846<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Non-pharmaceutical interventions, vaccination and the Delta variant: epidemiological insights from modelling England's COVID-19 roadmap out of lockdown\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.17.21262164\" target=\"_blank\" rel=\"noopener\">Non-pharmaceutical interventions, vaccination and the Delta variant: epidemiological insights from modelling England&#8217;s COVID-19 roadmap out of lockdown<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Sonabend, R., Whittles, L. K., Imai, N., Perez-Guzman, P. N., Knock, E. S., Rawson, T., Gaythorpe, K. A., Djaafara, B. A., Hinsley, W., FitzJohn, R. G., Lees, J. A., Thekke Kanapram, D., Volz, E. M., Ghani, A. C., Ferguson, N. M., Baguelin, M., Cori, A.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.17.21262164\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.17.21262164<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"SARS-CoV-2 alpha variant: is it really more deadly? A population-level observational study.\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.17.21262167\" target=\"_blank\" rel=\"noopener\">SARS-CoV-2 alpha variant: is it really more deadly? A population-level observational study.<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Moore, C. M., Sergienko, R., Arbel, R.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.17.21262167\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.17.21262167<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262149\" target=\"_blank\" rel=\"noopener\">Effectiveness of COVID-19 Vaccines among Incarcerated People in California State Prisons: A Retrospective Cohort Study<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Chin, E. T., Leidner, D. T., Zhang, Y., Long, E., Prince, L., Schrag, S. J., Verani, J. R., Wiegand, R. E., Alarid-Escudero, F., Goldhaber-Fiebert, J. D., Studdert, D. M., Andrews, J. R., Salomon, J. A.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262149\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.16.21262149<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Comparison of Antibody Levels in Response to SARS-CoV-2 Infection and Vaccination Type in a Midwestern Cohort\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262036\" target=\"_blank\" rel=\"noopener\">Comparison of Antibody Levels in Response to SARS-CoV-2 Infection and Vaccination Type in a Midwestern Cohort<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Remy, L., Tomomori-Sato, C., Conkright-Fincham, J., Wiedemann, L. M., Conaway, J. W., Unruh, J. R.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262036\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.16.21262036<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Worldwide association of lifestyle related factors and COVID-19 mortality\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.14.21257136\" target=\"_blank\" rel=\"noopener\">Worldwide association of lifestyle related factors and COVID-19 mortality<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Wang, J., Sato, T., Sakuraba, A. N.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.14.21257136\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.14.21257136<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"Significant reduction in humoral immunity among healthcare workers and nursing home residents 6 months after COVID-19 BNT162b2 mRNA vaccination\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262067\" target=\"_blank\" rel=\"noopener\">Significant reduction in humoral immunity among healthcare workers and nursing home residents 6 months after COVID-19 BNT162b2 mRNA vaccination<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Canaday, D. H., Oyebanji, O., Keresztesy, D., Payne, M., WIlk, D., Caris, L., Aung, H., St. Denis, K., Lam, E., Rowley, C., Berry, S., Cameron, C., Cameron, M., Wilson, B., Balazs, A., King, C., Gravenstein, S.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262067\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.15.21262067<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"The Impact of COVID-19 Testing on College Campuses\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262153\" target=\"_blank\" rel=\"noopener\">The Impact of COVID-19 Testing on College Campuses<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Yu, Z., Fujimoto, A. B., Keskinocak, P., Swann, J. L.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262153\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.16.21262153<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"DeepSARS: simultaneous diagnostic detection and genomic surveillance of SARS-CoV-2\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262126\" target=\"_blank\" rel=\"noopener\">DeepSARS: simultaneous diagnostic detection and genomic surveillance of SARS-CoV-2<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Yermanos, A., Hong, K.-L., Agrafiotis, A., Han, J., Nadeau, S., Valenzuela, C., Azizoglu, A., Ehling, R., Gao, B., Spahr, M., Neumeier, D., Chang, C.-H., Dounas, A., Petrillo, E., Nissen, I., Burcklen, E., Feldkamp, M., Beisel, C., Oxenius, A., Savic, M., Stadler, T., Rudolf, F., Reddy, S. T.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.16.21262126\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.16.21262126<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<div class=\"highwire-article-citation highwire-citation-type-highwire-article\">\n<div class=\"highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix\">\n<div class=\"cit-title\"><span class=\"highwire-cite-title\"> <a class=\"highwire-cite-linked-title\" title=\"The mental state of inpatients with COVID-19: a computational psychiatry approach\" href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262025\" target=\"_blank\" rel=\"noopener\">The mental state of inpatients with COVID-19: a computational psychiatry approach<\/a><\/span><\/div>\n<div class=\"highwire-cite-authors\"><span class=\"highwire-citation-authors\">Sorokin, M. Y., Palchikova, E. I., Kibitov, A. A., Kasyanov, E. D., Khobeysh, M. A., Zubova, E. Y.<\/span><\/div>\n<div class=\"highwire-cite-metadata\"><span class=\"highwire-cite-metadata-journal\"><a href=\"http:\/\/medrxiv.org\/cgi\/content\/short\/2021.08.15.21262025\" target=\"_blank\" rel=\"noopener\">10.1101\/2021.08.15.21262025<\/a> \u2014 Posted: 2021-08-18<\/span><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7: \u00ab\u0395\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03b9 \u03ba\u03b1\u03b9 \u03bc\u03b7 \u03ad\u03c7\u03bf\u03c5\u03bd \u03af\u03b4\u03b9\u03bf \u03b9\u03b9\u03ba\u03cc \u03c6\u03bf\u03c1\u03c4\u03af\u03bf &#8211; \u03a0\u03ad\u03c6\u03c4\u03b5\u03b9 \u03b7 \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c3\u03af\u03b1 \u03bc\u03b5\u03c4\u03ac \u03b1\u03c0\u03cc 3 \u03bc\u03ae\u03bd\u03b5\u03c2\u00bb -\u0386\u03c7\u03c1\u03b7\u03c3\u03c4\u03b1 \u03c4\u03b1 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03c4\u03b9\u03ba\u03ac \u00ab\u0397 \u0394\u03ad\u03bb\u03c4\u03b1 \u03bc\u03bf\u03bb\u03cd\u03bd\u03b5\u03b9 \u03b5\u03c5\u03ba\u03bf\u03bb\u03cc\u03c4\u03b5\u03c1\u03b1 \u03c4\u03bf\u03c5 \u03b5\u03bc\u03b2\u03bf\u03bb\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5\u03c2\u00bb \u039d\u03ad\u03b1 \u03bc\u03b5\u03b3\u03ac\u03bb\u03b7 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1 \u03c0\u03bf\u03c5\u00a0\u03b4\u03b9\u03b5\u03bd\u03b5\u03c1\u03b3\u03ae\u03b8\u03b7\u03ba\u03b5 \u03c3\u03c4\u03b7 \u0392\u03c1\u03b5\u03c4\u03b1\u03bd\u03af\u03b1 \u03b1\u03c0\u03cc \u03b5\u03b9\u03b4\u03b9\u03ba\u03bf\u03cd\u03c2 \u03c4\u03bf\u03c5 \u03c0\u03b1\u03bd\u03b5\u03c0\u03b9\u03c3\u03c4\u03b7\u03bc\u03af\u03bf\u03c5 \u03c4\u03b7\u03c2 \u039f\u03be\u03c6\u03cc\u03c1\u03b4\u03b7\u03c2 \u03b4\u03b5\u03af\u03c7\u03bd\u03b5\u03b9 \u03c0\u03c9\u03c2 \u03b7 \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c3\u03af\u03b1 \u03c0\u03bf\u03c5 \u03c0\u03c1\u03bf\u03c3\u03c6\u03ad\u03c1\u03bf\u03c5\u03bd \u03c4\u03b1 \u03b4\u03cd\u03bf \u03b5\u03bc\u03b2\u03cc\u03bb\u03b9\u03b1 \u03ba\u03b1\u03c4\u03ac \u03c4\u03b7\u03c2 COVID-19 \u03c0\u03bf\u03c5 \u03b1\u03be\u03b9\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7 \u03c7\u03ce\u03c1\u03b1 \u03b5\u03bd \u03bc\u03ad\u03c3\u03c9 &hellip; <\/p>\n<p><a class=\"more-link btn\" href=\"https:\/\/evaggelatos.com\/?p=22328\">\u03a3\u03c5\u03bd\u03ad\u03c7\u03b5\u03b9\u03b1 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22328","post","type-post","status-publish","format-standard","hentry","category-uncategorized","item-wrap"],"_links":{"self":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts\/22328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22328"}],"version-history":[{"count":9,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts\/22328\/revisions"}],"predecessor-version":[{"id":22339,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=\/wp\/v2\/posts\/22328\/revisions\/22339"}],"wp:attachment":[{"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/evaggelatos.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}